Clinical Pharmacy Clinical Guidelines
The clinical pharmacy guideline index: governing guidelines and standards for hospital medication use, from stewardship and vancomycin to USP 797 and ISMP.
The clinical pharmacy guideline library. This index lists the professional-society guidelines and standards-body documents that govern hospital medication use, with the publisher, current edition, scope, and a verified source for each. The multi-part syntheses that the site’s other departments carry are forthcoming for this department; until they publish, this index is the department’s source list.
Governing guidelines
| Guideline | Publisher | Edition | Scope | Source |
|---|---|---|---|---|
| Implementing an Antibiotic Stewardship Program | IDSA / SHEA | 2016 | Interventions that antibiotic stewardship programs can implement in emergency department, acute inpatient, and long-term care settings, including preauthorization and prospective audit and feedback | Clinical Infectious Diseases |
| Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review | ASHP / IDSA / PIDS / SIDP | 2020 | Dosing and monitoring of vancomycin in adult and pediatric patients with serious MRSA infection, replacing trough-based monitoring with AUC-guided monitoring | PubMed |
| IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections | IDSA | 2024 | Preferred and alternative treatment of ESBL-E, AmpC-E, CRE, DTR Pseudomonas aeruginosa, CRAB, and Stenotrophomonas maltophilia infections, including empiric therapy, oral transition, and duration | PubMed |
| ASHP Guidelines on Preventing Medication Errors in Hospitals | ASHP | 2018 | Recommendations for each step of the medication-use system, and the elements of a comprehensive medication safety program: a safety leader, an event reporting system, a medication safety team, and continuous quality improvement | AJHP |
| USP General Chapter 797, Pharmaceutical Compounding: Sterile Preparations | USP | 2023 revision (official 1 November 2023) | Standards for compounding sterile preparations, with Category 1, 2, and 3 CSPs, beyond-use dating, personnel competency, and facility requirements | USP |
| ISMP List of High-Alert Medications in Acute Care Settings | ISMP | 2024 | Medications that bear a heightened risk of significant patient harm when used in error, and the safeguards organizations apply to them | ISMP (PDF) |
| ISMP Targeted Medication Safety Best Practices for Hospitals | ISMP | 2024-2025 (22 best practices) | Consensus-based, high-leverage error-reduction practices addressing recurring causes of fatal and harmful medication errors, updated every two years | ISMP / ECRI |
| American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults | AGS | 2023 | Explicit list of medications best avoided by older adults in most circumstances or under specific diseases or conditions | PubMed |
| CDC Clinical Practice Guideline for Prescribing Opioids for Pain | CDC | 2022 | Whether to initiate opioids, opioid selection and dosage, duration and follow-up, and risk assessment for outpatients 18 years and older with acute, subacute, or chronic pain; excludes sickle cell disease, cancer pain, palliative, and end-of-life care | PubMed |
| KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease | KDIGO | 2024 | Evaluation and management of CKD, including a dedicated chapter on medication management and drug stewardship and the use of validated GFR estimating equations for drug dosing | KDIGO |
| 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation | ACC / AHA / ACCP / HRS | 2023 | Diagnosis and management of atrial fibrillation, including thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, ablation, and risk factor modification | Circulation |
| 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants | ACC | 2020 | Management of bleeding in patients on DOACs or vitamin K antagonists for any indication: bleed severity, medical and surgical management, reversal, and restarting anticoagulation | JACC |
How the series are built
Each guideline series on this site is a synthesis, not a summary of a single guideline. The relevant professional-society guidelines for a topic are read together, their recommendations integrated into one coherent clinical reference, and every substantive statement carries a numbered, DOI-linked citation back to its source. Long syntheses are split into sequential part pages so that each part loads fast and is individually citable. Every page carries a date (first published) and a lastmod (last substantive revision) in its metadata and JSON-LD; when a source society issues a new or updated guideline, the affected series is revised and its lastmod advances. Each series is reviewed by a clinician before it publishes. The series for this department are forthcoming and will be linked from this index and from the Clinical Pharmacy hub as they publish.
Frequently asked questions
What is in the clinical pharmacy guideline index?
How are the site's guideline series built?
When will the clinical pharmacy series publish?
No articles found
There are no articles in this section yet.